GlassScriptPhysician profile
Diane M Thomas
NPI 1124006044
$1,555.55
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $459 · 2020: $205 · 2021: $142 · 2022: $312 · 2023: $388 · 2024: $49.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $438.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $437.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $414.05 | 2019-2023 | Vraylar, Ubrelvy |
| Astrazeneca Pharmaceuticals LP | $341.22 | 2019-2024 | Saphnelo, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $234.07 | 2022 | |
| Novo Nordisk INC | $128.20 | 2020-2023 | Rybelsus |
| Edwards Lifesciences Corporation | $102.85 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Sanofi-Aventis U.S. LLC | $75.59 | 2019 | |
| Janssen Pharmaceuticals, INC | $72.32 | 2019 | |
| Lilly USA, LLC | $53.64 | 2022-2023 | Trulicity, Mounjaro |
| Horizon Therapeutics Plc | $36.98 | 2023 | Krystexxa |
| Glaxosmithkline, LLC. | $34.04 | 2022-2024 | Shingrix, Arexvy |
| Exact Sciences Corporation | $17.88 | 2024 | Cologuard Collection Kit |
| Kowa Pharmaceuticals America, INC. | $16.98 | 2023 | Seglentis |
| Bayer Healthcare Pharmaceuticals INC. | $15.60 | 2021 | |
| Merck Sharp & Dohme LLC | $12.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diane Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.